Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹255 Cr.
Stock P/E
-18.2
P/B
-21.1
Current Price
₹196
Book Value
₹ -9.3
Face Value
10
52W High
₹625
52W Low
₹ 150
Dividend Yield
0%

Kerala Ayurveda Overview

Business

Kerala Ayurveda Ltd. is an Indian company engaged in the manufacturing, marketing, and distribution of Ayurvedic products, along with providing Ayurvedic healthcare services. Its core business model is integrated, encompassing the production of classical and proprietary Ayurvedic medicines, dietary supplements, and personal care products, as well as operating Ayurvedic hospitals, wellness resorts, and clinics. The company also offers Ayurvedic education and training programs. Kerala Ayurveda makes money through the sale of its Ayurvedic formulations, revenue generated from its healthcare services (consultations, therapies, treatments), and fees from its educational initiatives, catering to both domestic and international markets.

Revenue Mix

While specific revenue contributions are not publicly detailed, Kerala Ayurveda Ltd.'s operations can be broadly categorized into:

Products: Manufacturing and sale of Ayurvedic medicines, herbal supplements, classical formulations, proprietary products, and personal care items. This segment likely forms a significant portion of revenue.

Services: Operating Ayurvedic hospitals, wellness centers, and clinics offering consultations, therapeutic treatments, and rejuvenation programs.

Education & Training: Providing courses and certifications in Ayurveda to students and practitioners.

Exports: Sales of its products and services to international markets.

Industry

Kerala Ayurveda operates within the Indian Pharmaceuticals & Drugs sector, specifically within the rapidly growing Ayurveda industry. The broader Indian AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homoeopathy) market is characterized by increasing consumer preference for natural remedies and wellness solutions, supported by government initiatives. The industry is fragmented, with a mix of large established players, regional companies, and numerous unorganized units. Kerala Ayurveda positions itself as an established, heritage brand with a focus on authentic classical Ayurvedic formulations and an integrated approach that combines product manufacturing with healthcare services and education. It leverages its "Kerala Ayurveda" brand, which carries a perception of authenticity and tradition, distinguishing it from general wellness brands or pure pharmaceutical players.

MOAT

Brand & Heritage: The "Kerala Ayurveda" brand itself evokes trust, authenticity, and traditional knowledge, which is a significant asset in the Ayurveda sector where consumer confidence in efficacy and purity is paramount. Its long-standing presence provides a legacy advantage.

Integrated Model: The combination of product manufacturing, healthcare services (clinics, hospitals, resorts), and education creates a synergistic ecosystem. This allows for direct feedback, research opportunities, and a comprehensive customer journey, potentially increasing customer loyalty and product adoption.

Deep Knowledge Base: Access to traditional Ayurvedic texts, experienced practitioners, and formulation expertise built over decades contributes to a strong R&D foundation for developing classical and proprietary products.

Growth Drivers

Increasing Awareness & Acceptance: Growing global and domestic demand for natural, holistic, and preventive healthcare solutions, coupled with rising interest in traditional medicine systems like Ayurveda.

Government Support: Initiatives by the Indian government (e.g., Ministry of AYUSH) promoting traditional medicine, standardization, and research.

Expansion of Distribution & Reach: Growing sales through modern trade, e-commerce platforms, and expanding clinic/resort footprint, both domestically and internationally.

Product Portfolio Expansion: Introduction of new classical and proprietary products in response to evolving consumer health needs.

Wellness Tourism: Leveraging its wellness resorts and services to tap into the growing health and medical tourism market.

Risks

Regulatory Scrutiny: Products, especially herbal medicines, face evolving regulatory challenges related to quality, efficacy claims, and ingredient sourcing in various markets.

Competition: Intense competition from other established Ayurvedic companies (e.g., Dabur, Patanjali, Himalaya), regional players, and conventional pharmaceutical companies entering the herbal segment.

Raw Material Volatility: Dependence on seasonal and often wild-crafted medicinal plants makes the company susceptible to price fluctuations, availability issues, and supply chain disruptions.

Quality Control & Standardization: Maintaining consistent quality and efficacy across a wide range of products and services is critical for brand reputation and consumer trust.

Perception & Efficacy: Challenges in establishing and proving scientific efficacy in line with modern medical standards, potentially leading to skepticism among some consumer segments.

Management & Ownership

Kerala Ayurveda Ltd. is typically a promoter-led company, characteristic of many heritage Indian businesses. The promoters usually bring a deep understanding of the core Ayurvedic principles and a long-term vision rooted in tradition. As a publicly listed entity, it would have a professional management team overseeing day-to-day operations and strategic growth, balancing traditional values with modern business practices. Ownership structure would include the promoter group holding a significant stake, alongside institutional and public shareholders.

Outlook

Kerala Ayurveda Ltd. operates in an industry experiencing significant tailwinds due to increasing health consciousness, a preference for natural solutions, and growing government support for traditional medicine. Its established brand, integrated business model, and legacy in authentic Ayurveda provide a strong foundation. The bull case hinges on the company's ability to effectively leverage its brand for geographical expansion, innovate its product portfolio, and scale its service offerings while maintaining strict quality control and regulatory compliance. The bear case involves challenges from intense competition, potential issues with raw material sourcing and pricing, and the ability to adapt to changing consumer demands and evolving regulatory landscapes, particularly concerning scientific validation and standardization of Ayurvedic products globally. Its future performance will depend on its capacity to blend traditional wisdom with modern business acumen and execution.

Kerala Ayurveda Share Price

Live · BSE · Inception: 1992
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Kerala Ayurveda Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 25 32 27 30 31 31 29 35 33 35
Other Income 0 -0 0 1 0 1 9 2 1 2
Total Income 25 32 28 31 31 32 38 37 34 37
Total Expenditure 24 27 27 25 32 41 33 40 34 42
Operating Profit 1 5 1 6 -1 -9 5 -3 -0 -5
Interest 1 3 0 1 0 2 1 3 3 1
Depreciation 0 1 0 2 1 2 2 1 1 2
Exceptional Income / Expenses 0 -1 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 3 -2 -14 3 -7 -4 -8
Provision for Tax 1 -0 -0 -0 1 2 1 -0 0 -1
Profit After Tax -1 1 0 4 -3 -15 2 -6 -5 -7
Adjustments -0 -0 -0 -0 -0 -0 -0 0 0 -0
Profit After Adjustments -1 0 0 3 -3 -16 2 -6 -4 -8
Adjusted Earnings Per Share -0.9 0.2 0.3 2.8 -2.4 -12.9 1.7 -5.3 -3.7 -6.1

Kerala Ayurveda Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 39 46 50 56 62 77 62 80 93 108 120 132
Other Income 0 1 0 0 1 0 0 0 0 1 2 14
Total Income 39 46 51 56 63 77 62 81 94 108 123 146
Total Expenditure 33 39 43 48 57 69 61 71 91 101 125 149
Operating Profit 6 8 7 8 5 7 1 10 3 7 -3 -3
Interest 2 2 1 2 3 2 6 7 5 5 4 8
Depreciation 1 2 2 2 1 1 1 1 1 1 5 6
Exceptional Income / Expenses 0 0 0 0 1 0 0 1 3 0 0 0
Profit Before Tax 3 4 4 4 3 5 -7 3 -1 1 -12 -16
Provision for Tax 1 1 1 1 1 0 -2 0 -0 2 2 0
Profit After Tax 3 3 3 3 3 4 -5 2 -0 -1 -14 -16
Adjustments -0 -0 -0 -0 -0 -0 0 -0 -0 -1 -1 0
Profit After Adjustments 2 3 3 3 2 4 -5 2 -1 -2 -15 -16
Adjusted Earnings Per Share 2.2 2.6 2.9 2.7 2.3 3.7 -4.6 2.2 -0.5 -1.3 -12.2 -13.4

Kerala Ayurveda Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds -9 -6 7 8 4 8 3 6 6 32 9
Minority's Interest 1 1 1 2 2 2 2 2 2 3 3
Borrowings 54 52 20 43 50 52 59 37 50 59 18
Other Non-Current Liabilities -1 1 4 5 10 10 8 5 4 6 5
Total Current Liabilities 25 24 48 45 28 31 42 60 53 40 88
Total Liabilities 71 73 81 103 92 103 114 110 115 141 124
Fixed Assets 33 34 34 32 33 33 33 44 46 46 47
Other Non-Current Assets 24 25 25 28 31 34 34 26 31 31 36
Total Current Assets 14 14 22 42 28 33 44 37 35 60 41
Total Assets 71 73 81 103 92 103 114 110 115 141 124

Kerala Ayurveda Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 2 2 3 7 5 6 19 3 4 23
Cash Flow from Operating Activities 0 6 4 -10 12 5 7 -1 10 2 5
Cash Flow from Investing Activities -0 -3 -3 -3 -3 -4 -1 -2 -7 -1 -15
Cash Flow from Financing Activities 2 -3 0 17 -12 1 6 -13 -1 18 -9
Net Cash Inflow / Outflow 2 -0 1 4 -2 2 12 -16 2 18 -19
Closing Cash & Cash Equivalent 2 2 3 7 5 6 19 3 4 23 3

Kerala Ayurveda Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.23 2.56 2.9 2.66 2.32 3.69 -4.59 2.24 -0.51 -1.3 -12.22
CEPS(Rs) 3.47 4.48 4.79 4.46 3.32 4.92 -3.38 3.41 0.64 0.4 -7.47
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) -8.44 -5.88 6.6 7.49 3.53 4.65 0.37 2.93 2.57 24.13 2.71
Core EBITDA Margin(%) 14.26 14.67 13.42 13.71 7.82 9.58 1.35 11.86 2.81 6.26 -3.98
EBIT Margin(%) 11.9 11.62 10.4 11.05 9.12 8.12 -0.52 11.79 4.96 5.5 -6.19
Pre Tax Margin(%) 7.66 8.45 7.75 7.08 4.98 5.91 -10.86 3.49 -0.6 1.18 -9.74
PAT Margin (%) 6.07 5.63 6.08 4.89 4.06 5.28 -7.8 2.98 -0.46 -0.8 -11.11
Cash Profit Margin (%) 8.83 9.72 9.37 8 5.64 6.77 -5.74 4.47 0.73 0.45 -7.15
ROA(%) 3.72 3.81 4.27 3.14 2.59 4.15 -4.47 2.14 -0.38 -0.67 -10.55
ROE(%) 0 0 862.54 38.72 43.39 93.9 -183.03 137.66 -14.76 -5.44 -86.43
ROCE(%) 8.35 9.15 8.91 8.88 7.64 9.27 -0.45 12.62 6.18 6.75 -8.94
Receivable days 31.35 29.69 30.44 31.76 36.2 41.85 61.85 53.75 51.38 48.66 51
Inventory Days 49.56 45.53 52.95 62.41 64.65 58.03 70.07 52.19 47.8 47.37 41.35
Payable days 187.68 141.98 123.71 142.11 134.74 164.33 186.13 183.24 169.01 155.66 128.93
PER(x) 17.32 21.28 32.09 31.63 28.84 9.91 0 34.93 0 0 0
Price/Book(x) -4.58 -9.26 14.09 11.24 18.92 7.87 140.57 26.68 32.49 10.83 129.43
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 2.78 2.7 3.01 2.82 2.05 1.26 1.81 1.86 1.69 3.35 4.03
EV/Core EBITDA(x) 17.85 16.22 20.53 18.87 23.76 13.07 117.92 15.14 54.32 49.67 -173
Net Sales Growth(%) 11.98 17.73 9.72 10.67 11.46 23.46 -19.15 29.45 16.25 15.46 11.57
EBIT Growth(%) 64.68 14.54 -0.74 15.99 -12.78 9.92 -105.22 3011.19 -51.06 27.92 -231.23
PAT Growth(%) 173.76 8.82 19.8 -12.18 -12.37 60.63 -219.5 149.42 -117.89 -101.52 -1517.68
EPS Growth(%) 216.58 14.68 13.24 -8.19 -12.95 59.43 -224.28 148.76 -122.61 -156.74 -840.72
Debt/Equity(x) -7.86 -11.05 8.1 9.51 16.57 13.08 198.89 22.6 27.42 2.4 20.21
Current Ratio(x) 0.54 0.56 0.45 0.93 1.03 1.08 1.04 0.61 0.67 1.49 0.46
Quick Ratio(x) 0.3 0.32 0.25 0.7 0.61 0.66 0.78 0.42 0.43 1.1 0.32
Interest Cover(x) 2.81 3.67 3.93 2.78 2.2 3.67 -0.05 1.42 0.89 1.27 -1.75
Total Debt/Mcap(x) 1.72 1.19 0.57 0.85 0.88 1.66 1.41 0.85 0.84 0.22 0.16

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +11% +14% +9% +12%
Operating Profit CAGR -143% 0% 0% 0%
PAT CAGR 0% 0% 0%
Share Price CAGR -53% +17% +28% +13%
ROE Average -86% -36% -30% +81%
ROCE Average -9% +1% +3% +6%

Kerala Ayurveda Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 35.61 %
FII 0.17 %
DII (MF + Insurance) 0.04 %
Public (retail) 64.39 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 63.4458.5858.5858.5858.5858.5837.8333.1433.1435.61
FII 000000000.220.17
DII 0.040.040.040.040.040.040.040.040.040.04
Public 36.5641.4241.4241.4241.4241.4262.1766.8666.8664.39
Others 0000000000
Total 100100100100100100100100100100

Kerala Ayurveda Peer Comparison

Pharmaceuticals & Drugs Edit Columns

Kerala Ayurveda Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Kerala Ayurveda Pros & Cons

Pros

  • Stock is trading at -21.1 times its book value
  • Debtor days have improved from 155.66 to 128.93days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 35.61%.
  • Company has a low return on equity of -36% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp